648
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Clinical and laboratory variables identifying bacterial infection and bacteraemia in the emergency department

, &
Pages 745-752 | Received 26 Sep 2011, Accepted 16 Apr 2012, Published online: 17 Jul 2012

References

  • Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115: 462–74.
  • Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118:146–55.
  • Zaidi M, Sifuentes-Osornio J, Rolon AL, Vazquez G, Rosado R, Sanchez M, . Inadequate therapy and antibiotic resistance. Risk factors for mortality in the intensive care unit. Arch Med Res 2002;33:290–4.
  • Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003;115:529–35.
  • Valles J, Rello J, Ochagavia A, Garnacho J, Alcala MA. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 2003;123:1615–24.
  • Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, . Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34: 1589–96.
  • Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004;164:637–44.
  • Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, . Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296–327.
  • Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, . BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009;64(Suppl 3):iii1–55.
  • Robenshtok E, Shefet D, Gafter-Gvili A, Paul M, Vidal L, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev 2008;(1): CD004418.
  • Stamm WE. Criteria for the diagnosis of urinary tract infection and for the assessment of therapeutic effectiveness. Infection 1992;20(Suppl 3):S151–4; discussion S60–1.
  • Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, . International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:e103–20.
  • Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, . Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010;50: 625–63.
  • Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, . Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41:1373–406.
  • Wistrom J, Norrby SR. Fluoroquinolones and bacterial enteritis, when and for whom? J Antimicrob Chemother 1995;36:23–39.
  • Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, . Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001;32: 331–51.
  • Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, . Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50:133–64.
  • Westling K, Aufwerber E, Ekdahl C, Friman G, Gardlund B, Julander I, . Swedish guidelines for diagnosis and treatment of infective endocarditis. Scand J Infect Dis 2007;39: 929–46.
  • Mandell GL, Bennett JE, Dolin R, Kelvin GV. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 7th ed. Edinburgh: Churchill Livingstone; 2009.
  • Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, . Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1–45.
  • Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, . Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52:427–31.
  • Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, . Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39: 1267–84.
  • Heimdahl A, Nord CE. Orofacial infections of odontogenic origin. Scand J Infect Dis Suppl 1983;39:86–91.
  • Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–55.
  • Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, . 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250–6.
  • Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, . Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003;326:41–4.
  • Cretikos MA, Bellomo R, Hillman K, Chen J, Finfer S, Flabouris A. Respiratory rate: the neglected vital sign. Med J Aust 2008;188:657–9.
  • Chan YL, Tseng CP, Tsay PK, Chang SS, Chiu TF, Chen JC. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care 2004;8:R12–20.
  • Gaini S, Koldkjaer OG, Pedersen C, Pedersen SS. Procalcitonin, lipopolysaccharide-binding protein, interleukin- 6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 2006;10:R53.
  • Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39:206–17.
  • Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006;34:1996–2003.
  • Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007; 7:210–7.
  • Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007;50:34–41.
  • Chirouze C, Schuhmacher H, Rabaud C, Gil H, Khayat N, Estavoyer JM, . Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 2002;35:156–61.
  • Delevaux I, Andre M, Colombier M, Albuisson E, Meylheuc F, Begue RJ, . Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 2003;62: 337–40.
  • Aikawa N, Fujishima S, Endo S, Sekine I, Kogawa K, Yamamoto Y, . Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 2005; 11:152–9.
  • Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011;171:1322–31.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.